When they are hormonal, when they are a warning – and the evidence-based approach to managing them

The Flutter That Frightens More Than Almost Any Other Symptom

You are lying in bed, almost asleep, when your heart suddenly lurches – a rapid fluttering, a brief pounding, a strange awareness of your own heartbeat that leaves you lying still, wondering if something is wrong. You are in the middle of a conversation and your heart briefly races for no apparent reason. You roll over and feel a missed beat followed by a heavy thump. You check your pulse and find it running faster than it should be at rest.

Heart palpitations during perimenopause are one of the most frightening and least discussed symptoms of this transition. The fear is understandable: heart symptoms carry a weight that hot flushes and mood changes do not. When the heart does something unexpected, the instinct is to worry.

Studies suggest that up to 42% of women in perimenopause and 54% of postmenopausal women experience palpitations at some point, often triggered by fluctuating estrogen and progesterone levels. A 2025 study investigating common symptoms of perimenopause identified heart palpitations as one of eight symptoms significantly associated with the transition.

In the majority of cases, perimenopausal heart palpitations are hormonal, benign, and manageable. But the minority that are not benign can be serious – and knowing the difference is the most important clinical task this article can help you with.

Part 1: Why Menopause Affects the Heart’s Rhythm

Estrogen and the Autonomic Nervous System

The mechanism connecting falling estrogen to heart palpitations is well-established and mechanistically coherent. Estrogen is not only a cardiovascular vasodilator and lipid regulator – it is a direct modulator of the autonomic nervous system: the neural control system that governs heart rate, heart rhythm, blood pressure, and breathing.

Estrogen influences how your body regulates heart rate and blood pressure. As levels drop, your nervous system may overreact, causing an irregular heartbeat. Increased sensitivity to stress hormones like cortisol and adrenaline can make your heart feel like it’s beating faster or harder than normal. 

Estrogen helps regulate the sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) branches of the autonomic nervous system. When estrogen fluctuates, the sympathetic nervous system can become overactive, leading to an increased heart rate, enhanced sensitivity to catecholamines (adrenaline and noradrenaline), and reduced heart rate variability – the beat-to-beat variation in heart rhythm that reflects a healthy, responsive cardiovascular system. When heart rate variability decreases, the heart becomes less adaptable to physiological demands and more prone to the ectopic beats and rhythm irregularities experienced as palpitations.

The Hot Flush Connection

Perimenopause heart palpitations are closely linked with vasomotor symptoms. Your heart rate can increase by 8 to 16 beats per minute during a hot flush. This acute tachycardia during flushing is not simply a perceived sensation – it is a measurable physiological event. The vasodilation that produces a hot flush triggers a compensatory sympathetic response that accelerates heart rate and, in susceptible women, can precipitate ectopic beats or brief atrial arrhythmias that are experienced as palpitations.

The timing of palpitations – night-time, often accompanying night sweats, and particularly during the cooling phase after a hot flush – is a clinical signature of this vasomotor mechanism.

Estrogen’s Cardioelectrical Effects

Research suggests that estrogen can have a stabilizing effect on your heart rate. This stabilizing effect operates at the level of cardiac ion channels – the electrical gates that govern the flow of sodium, potassium, and calcium ions that produce each heartbeat.

Estrogen prolongs the cardiac refractory period (the window during which the heart cannot be re-stimulated) and modulates potassium channel function in a way that suppresses ectopic foci – the electrical irritability points from which abnormal beats originate. When estrogen falls, these stabilizing effects are withdrawn, and the heart’s electrical system becomes more reactive to the same physiological stimuli that were previously handled without symptomatic consequence.

Importantly, postural orthostatic tachycardia syndrome (POTS) – an autonomic disorder producing rapid heart rate on standing, palpitations, and lightheadedness – has a striking epidemiological association with the perimenopausal period. The majority of women with POTS onset around perimenopause, menopause, and postmenopausal age, highlighting the role of declining hormonal levels as a disease trigger. POTS in perimenopausal women is underdiagnosed and should be considered when palpitations are associated with positional change and lightheadedness.

The Cortisol Amplifier

The elevated cortisol reactivity of perimenopause – driven by loss of estrogen’s buffering of the HPA axis – directly worsens palpitation frequency and severity. Adrenaline and noradrenaline (released in the stress response) are direct cardiotonic stimulants: they increase heart rate, increase cardiac contractility, and lower the threshold for ectopic beats. The perimenopausal nervous system’s heightened sensitivity to these stress hormones means that ordinary physiological stressors – caffeine, alcohol, exercise, anxiety, dehydration – produce more pronounced cardiac responses than in younger women with normal estrogen levels.

Additional Contributing Factors

Several other mechanisms contribute to palpitations during this transition:

Sleep deprivation – fragmented sleep from night sweats directly increases sympathetic tone, reduces heart rate variability, and dramatically increases palpitation frequency. Each awakening from a night sweat involves a brief surge of adrenaline that can precipitate ectopic beats.

Anxiety – significantly elevated during perimenopause due to the same neurochemical changes driving other symptoms. Anxiety independently causes palpitations through hyperventilation-induced respiratory alkalosis and direct sympathetic activation. The loop between palpitations and anxiety is self-reinforcing: palpitations provoke anxiety, which provokes more palpitations.

Dehydration – hot flushes and night sweats increase fluid loss. Dehydration reduces plasma volume, increasing the concentration of electrolytes and the resting heart rate, and lowers the threshold for ectopic beats.

Caffeine, alcohol, and stimulants – at unchanged consumption levels, these trigger stronger palpitation responses in perimenopausal women than they did previously – because the autonomic nervous system’s sensitivity to catecholamines has increased.

Thyroid dysfunction – both hypothyroidism and hyperthyroidism produce palpitations and are significantly more common in perimenopausal women. The overlap with hormonal palpitations makes clinical distinction important.

Part 2: What Palpitations Feel Like – The Different Presentations

Understanding the character and timing of palpitations helps in identifying their likely cause:

Ectopic beats (extra beats or missed beats) – felt as a “skipped” beat followed by a heavy thump, or an extra beat that arrives too early and then is followed by a compensatory pause. These are typically premature atrial contractions (PACs) or premature ventricular contractions (PVCs). They are the most common form of menopausal palpitations – almost universally benign in the absence of structural heart disease – and are typically increased by caffeine, alcohol, fatigue, and stress.

Sinus tachycardia – an appropriately but noticeably fast heartbeat, typically 90–110 bpm at rest, felt as an awareness of the heart beating rapidly. Common during and immediately after hot flushes, associated with the vasomotor response.

Atrial fibrillation (AF) – an irregular, chaotic heart rhythm that produces a persistently irregular pulse (irregularly irregular) and may be accompanied by breathlessness, chest discomfort, and lightheadedness. AF requires urgent assessment and is the form of palpitation that is most clinically important not to dismiss as hormonal.

Night-time palpitations on waking – typically associated with a night sweat episode; the adrenaline surge of waking combines with the thermal flush to produce tachycardia and ectopic beats.

Positional palpitations – palpitations that occur consistently on standing up, associated with lightheadedness, suggesting POTS or orthostatic hypotension rather than purely cardiac arrhythmia.

Part 3: When Palpitations Are a Warning – The Red Flags That Require Urgent Assessment

This is the most important section of this article, and the one that should be read first if you are experiencing palpitations now.

Seek emergency medical assessment (call 999/112 or go to A&E/emergency room) for:

• Palpitations accompanied by chest pain or chest pressure – particularly if radiating to the jaw, left arm, or back
• Palpitations accompanied by breathlessness at rest that is new or worsening
• Palpitations accompanied by fainting or near-fainting (syncope or presyncope)
• Palpitations accompanied by sudden severe headache or new neurological symptoms (weakness, speech difficulty, visual changes) – these may indicate a cerebrovascular event related to AF
• Palpitations that are very rapid (above 150 bpm) and sustained – particularly if regular and mechanically distinct from the ectopic beats described above
• Palpitations in a woman with known heart disease, structural heart abnormality, or previous arrhythmia

Seek prompt (same-day or next-day) clinical assessment for:

• Palpitations that are persistently irregular – an irregularly irregular pulse at rest may indicate atrial fibrillation, which requires ECG confirmation and appropriate management
• Palpitations that are new, frequent, and worsening over days or weeks
• Palpitations associated with significant anxiety, difficulty functioning, or preventing sleep – warranting both clinical evaluation and psychological support

Seek clinical assessment within a week or so for:

• Palpitations that are new to you and have not been evaluated – even if brief and apparently benign
• Palpitations in a woman with risk factors for heart disease (hypertension, diabetes, elevated cholesterol, significant smoking history, family history of early heart disease)
• Palpitations in a woman with symptoms suggesting thyroid dysfunction (unexplained weight change, cold or heat intolerance, hair loss disproportionate to expected, excessive fatigue)

The clinical investigations to request:

• 12-lead ECG – identifies structural conduction abnormalities, ST changes, QT interval prolongation, and any arrhythmia present at the time of recording
• 24-hour (Holter) monitor – a wearable ECG that records cardiac rhythm continuously over 24 hours; captures ectopic beats and intermittent arrhythmias that an ECG may miss

• Event recorder – a longer-duration wearable (2–4 weeks) that captures and transmits an ECG when triggered by symptoms; most useful for infrequent palpitations that are unlikely to be captured on a 24-hour monitor
• Thyroid function (TSH) – essential, given the overlap of thyroid dysfunction with menopausal palpitations
• Full blood count – anaemia produces tachycardia and palpitations and is common in perimenopausal women with heavy periods
• Electrolytes (potassium, magnesium, calcium) – abnormalities in any of these directly produce cardiac arrhythmias
• Echocardiogram – ultrasound assessment of cardiac structure and function; indicated if there are clinical features suggesting structural heart disease

Part 4: The Evidence-Based Management Approach

1. Addressing the Hormonal Root Cause

For palpitations that are clearly hormonal – occurring in the context of hot flushes, associated with perimenopause onset, and absent any clinical red flags – the most direct management is addressing the hormonal environment.

A systematic review of menopausal symptom treatment options and palpitations found evidence that treatments addressing the hormonal root of menopause symptoms can also reduce palpitation frequency. Some research suggests that MHT with estrogen and progesterone can help manage heart palpitations during perimenopause and menopause. By restoring the autonomic nervous system regulation that estrogen normally provides, MHT addresses the primary mechanism driving hormonal palpitations. The reduction in vasomotor symptoms also indirectly reduces the acute tachycardia episodes that accompany hot flushes.

Oral micronised progesterone deserves specific mention: progesterone has direct antiarrhythmic properties mediated through its effects on cardiac potassium channels – it partially restores the refractory period prolongation that estrogen normally provides. Women who report that palpitations began when their progesterone fell in early perimenopause may notice specific improvement with progesterone-containing MHT.

The POTS context: for perimenopausal women with confirmed or suspected POTS, hormone therapy with fludrocortisone-sparing effects (maintaining sodium and blood volume) alongside adequate fluid intake and salt represents the most evidence-supported management approach, and MHT may specifically improve POTS symptoms in postmenopausal women through autonomic nervous system restoration.

2. Treating Hot Flushes to Reduce Palpitation Episodes

Since hot flushes and palpitations are mechanistically linked – through the shared vasomotor-adrenaline-sympathetic pathway – any intervention that reduces hot flush frequency and severity will reduce the associated palpitation episodes.

For women who cannot or prefer not to use MHT, the non-hormonal vasomotor options include:

• Fezolinetant (NK3 receptor antagonist) – specifically approved for vasomotor symptoms; reduces hot flush frequency by 60–74%
• SSRIs and SNRIs (particularly venlafaxine and paroxetine) – reduce hot flush frequency and additionally have direct cardiac electrophysiological effects; note that paroxetine and some other SSRIs can modestly prolong the QTc interval and should be used with awareness in women with arrhythmia history
• Clonidine – an alpha-2 adrenergic agonist that reduces sympathetic nervous system activation; reduces both hot flushes and the sympathetically-mediated palpitations associated with them; available as patch or tablet
• 3. Lifestyle Modifications with Direct Evidence
• Caffeine reduction or elimination – caffeine is a direct cardiac stimulant through adenosine receptor blockade. In perimenopausal women with heightened sympathetic sensitivity, caffeine at previously tolerated levels now produces more pronounced ectopic beats and tachycardia. A systematic trial of caffeine elimination (minimum 2 weeks to assess response) frequently produces dramatic reduction in palpitation frequency. This includes coffee, tea, energy drinks, and cola.
• Alcohol reduction or elimination – alcohol produces palpitations through multiple mechanisms: it raises heart rate acutely through its vasodilatory and sympathetic effects; it disrupts sleep architecture, increasing overnight adrenaline surges; it can directly trigger AF in susceptible women (“holiday heart syndrome”); and it worsens dehydration. The perimenopausal reduction in estrogen-mediated cardiac stability means that alcohol at unchanged consumption levels now produces more cardiac reactivity than before.
• Hydration – maintaining adequate fluid intake directly reduces palpitation frequency by maintaining plasma volume, stabilizing electrolyte concentrations, and reducing the resting tachycardia of dehydration. A minimum of 2 liters daily with additional fluid to compensate for losses from hot flushes and night sweats.
• Magnesium – this is the most clinically important supplement for cardiac rhythm stability. Magnesium is an essential cofactor for the Na-K-ATPase pump that maintains cardiac cell membrane potential, and a co-modulator of calcium channels in cardiac muscle. Magnesium deficiency – prevalent in 40–60% of perimenopausal women – is directly associated with increased ectopic beat frequency, reduced heart rate variability, and susceptibility to atrial arrhythmias. Magnesium glycinate (300–400 mg at night) or magnesium taurate (specifically formulated for cardiac support) at the same dose is evidence-supported and well-tolerated. Many women with perimenopausal palpitations report significant improvement within 2–4 weeks of consistent magnesium supplementation.
• Potassium and electrolyte balance – alongside magnesium, potassium is the electrolyte most directly responsible for cardiac rhythm stability. Adequate dietary potassium (from vegetables, legumes, avocado, bananas, salmon) prevents the potassium depletion that increases ectopic beat frequency. Women on diuretics for hypertension should have potassium levels monitored regularly.
• Stress management and the sympathetic-parasympathetic balance – techniques that activate the parasympathetic nervous system (rest-and-digest) directly reduce palpitation frequency by counteracting the sympathetic overactivation that estrogen loss produces.
• Vagal maneuvers for acute episodes – the Valsalva maneuver (bearing down as if having a bowel movement), diving reflex (immersing the face in cold water for 30 seconds), and carotid sinus massage (firm circular pressure on the carotid pulse in the neck – only appropriate if structural heart disease has been excluded) activate the vagus nerve and can terminate some forms of rapid palpitation or supraventricular tachycardia acutely. These are worth knowing and practicing with clinician guidance.
• Avoiding known triggers – beyond caffeine and alcohol, common palpitation triggers include: large meals (which divert blood flow to the digestive system and can trigger vagal responses); lying on the left side (which can increase awareness of the heartbeat in susceptible women); intense exercise without adequate warm-up; extreme heat; and, paradoxically, some sleep positions in women with GERD (gastro-esophageal reflux disease, which can cause palpitations through esophago-cardiac reflexes).

4. Breathing and Mind-Body Approaches

• Diaphragmatic breathing – slow, deep, belly-focused breathing at 4–6 breaths per minute directly activates the vagus nerve and produces measurable reduction in heart rate and increase in heart rate variability within minutes. This is not a vague relaxation recommendation – it is a direct parasympathetic intervention with well-documented cardiac electrophysiological effects.
• Mindfulness-based stress reduction (MBSR) – consistent mindfulness practice reduces the sympathetic reactivity that amplifies palpitations, lowers circulating cortisol and adrenaline, and improves heart rate variability. Women who practice mindfulness consistently for 8 weeks show measurable improvements in autonomic nervous system function that directly reduce palpitation frequency.
• Yoga and tai chi – both produce parasympathetic activation, reduce sympathetic reactivity, and improve heart rate variability. Regular practice (two to three sessions weekly) produces gradual but significant improvement in cardiac autonomic function.

5. Sleep Optimization

• Treating the underlying causes of sleep disruption is one of the most direct interventions for reducing palpitation frequency. Each night sweat episode is a palpitation trigger – through the acute adrenaline surge of waking from thermal disturbance. Reducing night sweats through hormonal or non-hormonal treatment reduces both the sleep disruption and the associated nocturnal palpitations.
• CBT for insomnia (CBT-I) reduces the anxiety that amplifies palpitation perception and improves sleep architecture in ways that reduce overnight sympathetic surges

6. Addressing Anxiety

• The bidirectional loop between palpitations and anxiety – palpitations cause anxiety, anxiety causes palpitations – is one of the most clinically important dynamics of perimenopausal cardiac symptoms. Women who develop significant anxiety about palpitations (cardiophobia) experience dramatically more frequent and more distressing episodes through anticipatory sympathetic activation.
• CBT – specifically, the interoceptive exposure component of CBT for health anxiety – directly reduces cardiac symptom amplification by systematically reducing the threat response to benign cardiac sensations. This is not dismissing the palpitations as psychological – it is treating the neurological circuit that is magnifying a physiological symptom into a functionally debilitating experience.

7. Specific Cardiac Management for Non-Hormonal Palpitations

• For women in whom Holter monitoring or event recording identifies a specific arrhythmia, management follows arrhythmia-specific clinical protocols:
• Frequent PVCs or PACs – beta-blockers (bisoprolol, atenolol) at low doses significantly reduce the frequency of ectopic beats and are the pharmacological first-line in women with frequent, symptomatic ectopic beats who have not responded to the lifestyle modifications above. They also reduce the cardiac response to sympathetic activation during hot flushes.
• Atrial fibrillation – requires formal cardiological assessment, anticoagulation risk stratification (using the CHA₂DS₂-VASc score), rate or rhythm control, and specialist follow-up. AF in perimenopausal women is not simply a hormonal symptom – it is a medical condition requiring specific management.
• Supraventricular tachycardia (SVT) – episodic rapid regular tachycardia that starts and stops abruptly. Responds to vagal maneuvers acutely; pharmacological management with beta-blockers or calcium channel blockers for prevention; catheter ablation as a curative option for recurrent, symptomatic SVT.

Part 5: The Practical Action Plan

Daily foundations:

• Reduce or eliminate caffeine, particularly afternoon and evening consumption
• Limit alcohol; consider complete elimination if palpitations are frequent
• Drink at minimum 2 liters of water daily
• Magnesium glycinate 300–400 mg at night
• 5 minutes of slow diaphragmatic breathing daily (4–6 breaths per minute)
• Adequate, magnesium-rich dietary intake (pumpkin seeds, dark leafy greens, almonds, avocado)

For acute palpitation episodes:

• Sit down and check your pulse (wrist or neck) – note whether it is regular or irregular, and the approximate rate
• Try diaphragmatic breathing or the Valsalva maneuver
• Cold water on the face (stimulates the diving reflex)
• Avoid the impulse to catastrophize – most hormonal palpitations resolve within seconds to a few minutes
• Keep a brief log: time, duration, character (regular or irregular), what triggered it, how it resolved

Clinical assessment – always seek:

• A baseline ECG at perimenopause onset, even if palpitations are absent
• Thyroid function, full blood count, and electrolytes
• If palpitations are frequent: 24-hour Holter monitor or event recorder

Conversations to have with your clinician:

• Discuss MHT as a mechanism-targeted approach if palpitations coincide with hot flushes and other menopausal symptoms
• Discuss beta-blockers if palpitations are frequent, distressing, and not responding to lifestyle measures
• Request cardiology referral if palpitations are associated with any of the red-flag features described above

The Conclusion

Heart palpitations during perimenopause and menopause are among the most frightening and most misunderstood symptoms of this transition. They affect the majority of women during this period, they arise from clearly identifiable hormonal mechanisms, and – in their benign hormonal form – they are highly responsive to the interventions described above.

Research suggests there is no direct connection between hormonal palpitations and an increased risk of heart disease in women experiencing perimenopause and menopause. Studies have not found a link between these palpitations and measures of heart health like atherosclerosis, coronary artery calcium, or blood pressure. The ectopic beats and fleeting tachycardia of the hormonal heart are not the precursors to heart attack or dangerous arrhythmia that fear makes them feel like.

But the minority of palpitations that are not benign do require assessment. The red flags are clear, the investigations are accessible, and the management is well-established.

Know the difference. Seek assessment when the warning signs are present. Manage the hormonal symptoms with the full toolkit the evidence supports. And know that your heart, in the vast majority of cases, is telling you that it is adjusting to a new hormonal environment – not that something is fundamentally wrong.

For more useful articles and expert guidance, explore the Womeno app – your personal digital companion through the hormonal transition. Download the app HERE

Sources

1. Sheng Y, Carpenter JS, Elomba CD et al. Effect of menopausal symptom treatment options on palpitations: A systematic review. Climacteric. 2022;25(2):128–140. PMC9710005. doi:10.1080/13697137.2021.1948006
2. Carpenter JS et al. Palpitations across the Menopause Transition in SWAN: Trajectories, Characteristics, and Associations with Subclinical Cardiovascular Disease. Menopause. 2023;30(1):18–27. doi:10.1097/GME.0000000000002082
3. Dr. Brighten J. Heart Palpitations in Menopause: What Every Woman Needs to Know. drbrighten.com. December 2024; reviewed April 2025. (Citing: 42% peri / 54% post prevalence data; ANS mechanism; 2025 perimenopause symptoms study)
4. Forhers.com / Hers Medical Team. Perimenopause Heart Palpitations: What Causes Them and How They’re Treated. forhers.com. December 2025. (Citing: NIA 2024; Saleh TM 2007; Schwarz KG 2023; Sheng Y 2022)
5. Menopause Mastery / Dr. Davis J MD CMP. Perimenopause Heart Palpitations Before Period. mlrb.net. September 2025. (Detailed ANS and cardiac electrophysiology mechanism)
6. Versalie / Kenvue. Perimenopause and Heart Palpitations. versalie.com. May 2025. (Citing: Sheng Y 2022 systematic review; Zeitler EP et al. 2022 arrhythmias in female patients)
7. BW Healthcare World. Palpitations Around Periods or Menopause: Hormones and the Heart.bwhealthcareworld.com. February 2026.
8. Healthline. Understanding the Connection Between Menopause and Heart Rate Changes. healthline.com. Updated 2024. 
9. PMC12941859. Postural Orthostatic Tachycardia Syndrome, Menopause and Hormone Replacement Therapy: Clinical Decisions in Times of Uncertainty. PMC. 2025. (POTS and perimenopause epidemiology) 
10. Schwarz KG, Low DA, Lucas RAI. Autonomic nervous system dysfunction throughout menopausal transition: A potential mechanism underpinning cardiovascular and cognitive alterations during female ageing. Journal of Physiology. 2023;601(16):3417–3438. doi:10.1113/JP285126
11. Saleh TM et al. Role of oestrogen in the central regulation of autonomic function. Clinical and Experimental Pharmacology and Physiology. 2007;34(7):617–623. PMID:17645624 
12. Flo Health. Heart palpitations in perimenopause: Are they a thing? flo.health. February 2025. (Citing: SWAN study; MsFLASH; Carpenter JS 2023) 
13. AOL / Hers Editorial. Perimenopause heart palpitations: Your treatment options. aol.com. 2025. (Citing: 20–40% prevalence systematic review 2021; 2025 perimenopause symptoms study) 
14. Manson JE et al. Menopause Transition and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association. Circulation. 2020;142(25):e506–e532. doi:10.1161/CIR.0000000000000912 
15. Udell JA et al. Effect of cardiovascular medications on palpitations in women. JAMA Cardiology. 2024. (Beta-blocker evidence for ectopic beat management)
16. Nielsen JB, Kühl JT, Pietersen A et al. P-wave duration and the risk of atrial fibrillation. Heart Rhythm. 2015;12(8):1684–1692. (AF risk and hormonal context) 
17. Cleveland Clinic. Heart Palpitations and Anxiety. my.clevelandclinic.org. Updated 2025. 
18. American College of Cardiology. Heart Health Declines Rapidly after Menopause. acc.org. April 2, 2024. 
19. Zeitler EP et al. Arrhythmias in female patients: Incidence, presentation and management. Circulation: Arrhythmia and Electrophysiology. 2022. doi:10.1161/CIRCEP.121.009905 
20.  Carpenter JS et al. A Menopause Strategies-Finding Lasting Answers for Symptoms and Health (MsFLASH) Investigation of Self-Reported Menopausal Palpitation Distress. Journal of Women’s Health. 2021;30(4):533–538. doi:10.1089/jwh.2020.8586